The lower APE1 activity in the AD group of our study (Table 2) is consistent with high oxidative DNA damage; however, the slight inverse trend of APE1 activity with AD progression in our AD group is not consistent with reduced oxidative DNA damage as AD pathology progresses. Here, APEX1 is linked to Alzheimer disease.